Related Experiment Video

Updated: Aug 4, 2026

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
15:18

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure

Published on: July 30, 2009

Randomized clinical trials in infancy: methodologic issues

L T Singer1

  • 1Department of Pediatrics, Rainbow Babies and Childrens Hospital, Case Western Reserve University, School of Medicine, Cleveland, OH 44106, USA. LXS5@PO.CWRU.EDU

Seminars in Neonatology : SN
|May 4, 2002
PubMed

Insights

Early infant formula supplementation with long-chain polyunsaturated fatty acids (LCPUFAs) requires rigorous trials. Methodological challenges in infant studies necessitate long-term follow-up to assess cognitive development and safety.

Area of Science:

  • Pediatrics
  • Neuroscience
  • Nutrition Science

Background:

  • Randomized clinical trials (RCTs) are needed to evaluate infant formula supplemented with long-chain polyunsaturated fatty acids (LCPUFAs).
  • Infant development, particularly the central nervous system, is complex and influenced by numerous environmental factors.
  • Current infant cognitive assessments lack long-term predictive validity, complicating intervention studies.

Purpose of the Study:

  • To highlight the necessity for robust clinical trials on LCPUFA supplementation in infant formulas.
  • To identify key methodological challenges in conducting infant intervention studies.
  • To emphasize the need for extended follow-up periods in LCPUFA trials.

Main Methods:

  • Discusses the challenges in designing and executing RCTs for infant nutritional interventions.
  • Highlights the limitations of current infant cognitive development assessments.
  • Stresses the importance of considering confounding variables, selection bias, and attrition rates.

Main Results:

  • RCTs for LCPUFA supplementation in infant formulas face significant methodological hurdles.
  • Infant cognitive assessments in the first year are unstable and poorly predictive of later outcomes.
  • Many existing studies, especially for preterm infants, suffer from small sample sizes and high attrition.

Conclusions:

  • Intervention trials for LCPUFA supplementation must extend beyond two years of life.
  • Careful attention to study design, bias, and mediating factors is crucial.
  • Determining the benefits versus risks of LCPUFA supplementation requires methodologically sound, long-term research.

More Related Videos

A Novel Experimental and Analytical Approach to the Multimodal Neural Decoding of Intent During Social Interaction in Freely-behaving Human Infants11:14

A Novel Experimental and Analytical Approach to the Multimodal Neural Decoding of Intent During Social Interaction in Freely-behaving Human Infants

Published on: October 4, 2015

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Related Concept Videos

Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...